ATNM
Actinium Pharmaceuticals, Inc.
AMEXHealthcareBiotechnologyUS
Rating:C-
Company Profile
CEO
Sandesh C. Seth
IPO Date
2012-12-27
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Actinium Pharmaceuticals, Inc.
CEO
Sandesh C. Seth
IPO Date
2012-12-27
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
| 2,500 |
| $10.41 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 2,500 | $23.49 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 8,333 | $6.96 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 8,333 | $9.55 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 18,351 | $6.07 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 72,156 | $4.96 |
| 2 Apr 2025 | Chell Jeffrey W. | director | D-Return | Disposed | 70,311 | $5.00 |
| 2 Apr 2025 | O'Loughlin Steve | Chief Financial Officer | D-Return | Disposed | 3,333 | $53.70 |
| 2 Apr 2025 | O'Loughlin Steve | Chief Financial Officer | D-Return | Disposed | 1,666 | $59.70 |